Hologic Valuation
| HO1 Stock | EUR 63.00 1.00 1.61% |
At this time, the firm appears to be fairly valued. Hologic retains a regular Real Value of €61.86 per share. The prevalent price of the firm is €63.0. Our model calculates the value of Hologic from evaluating the firm fundamentals such as Current Valuation of 14.11 B, return on equity of 0.11, and Return On Asset of 0.0743 as well as inspecting its technical indicators and probability of bankruptcy.
Price Book 3.2084 | Enterprise Value 14.1 B | Enterprise Value Ebitda 15.7347 | Price Sales 3.4544 | Forward PE 16.5017 |
Fairly Valued
Today
Please note that Hologic's price fluctuation is very steady at this time. Calculation of the real value of Hologic is based on 3 months time horizon. Increasing Hologic's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Hologic stock is determined by what a typical buyer is willing to pay for full or partial control of Hologic. Since Hologic is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Hologic Stock. However, Hologic's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 63.0 | Real 61.86 | Hype 63.0 | Naive 61.53 |
The real value of Hologic Stock, also known as its intrinsic value, is the underlying worth of Hologic Company, which is reflected in its stock price. It is based on Hologic's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Hologic's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Hologic helps investors to forecast how Hologic stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Hologic more accurately as focusing exclusively on Hologic's fundamentals will not take into account other important factors: Hologic Cash |
|
Hologic Total Value Analysis
Hologic is currently estimated to have takeover price of 14.11 B with market capitalization of 14.25 B, debt of 2.9 M, and cash on hands of 601.8 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Hologic fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
14.11 B | 14.25 B | 2.9 M | 601.8 M |
Hologic Investor Information
About 97.0% of the company shares are owned by institutional investors. The book value of Hologic was currently reported as 19.85. The company has Price/Earnings To Growth (PEG) ratio of 1.51. Hologic had not issued any dividends in recent years. Based on the measurements of operating efficiency obtained from Hologic's historical financial statements, Hologic is performing exceptionally good at this time. It has a great probability to report excellent financial results in March.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total Cash From Operating Activities | 1.1 B | 1.2 B |
|
|
Hologic Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Hologic has an asset utilization ratio of 45.49 percent. This implies that the Company is making €0.45 for each dollar of assets. An increasing asset utilization means that Hologic is more efficient with each dollar of assets it utilizes for everyday operations.Hologic Profitability Analysis
Based on the measurements of profitability obtained from Hologic's financial statements, Hologic may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in March. Profitability indicators assess Hologic's ability to earn profits and add value for shareholders.Net Income | First Reported 2017-03-31 | Previous Quarter 187.2 M | Current Value 179.1 M | Quarterly Volatility 248.1 M |
For Hologic profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Hologic to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Hologic utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Hologic's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Hologic over time as well as its relative position and ranking within its peers.
Hologic Earnings per Share Projection vs Actual
By analyzing Hologic's earnings estimates, investors can diagnose different trends across Hologic's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Hologic is based on EPS before non-recurring items and includes expenses related to employee stock options.Hologic Ownership Allocation
Hologic has a total of 223.24 Million outstanding shares. The majority of Hologic outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Hologic to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Hologic. Please pay attention to any change in the institutional holdings of Hologic as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Hologic Profitability Analysis
The company reported the revenue of 4.1 B. Net Income was 565.7 M with profit before overhead, payroll, taxes, and interest of 2.49 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Hologic's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Hologic and how it compares across the competition.
About Hologic Valuation
The stock valuation mechanism determines Hologic's current worth on a weekly basis. Our valuation model uses a comparative analysis of Hologic. We calculate exposure to Hologic's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Hologic's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 2.4 B | 2.3 B |
Complementary Tools for Hologic Stock analysis
When running Hologic's price analysis, check to measure Hologic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hologic is operating at the current time. Most of Hologic's value examination focuses on studying past and present price action to predict the probability of Hologic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hologic's price. Additionally, you may evaluate how the addition of Hologic to your portfolios can decrease your overall portfolio volatility.
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |